Xin-Qiang Lan

Dr. Xin-Qiang Lan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2023 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
HZHui‐Jie Zhang
Hui‐Jie Zhang
BWBen‐Hui Wang
Ben‐Hui Wang
XWXiang Wang
Xiang Wang
CHChun‐Ping Huang
Chun‐Ping Huang
SXSi‐Man Xu
Si‐Man Xu
YXYang Xiang
Yang Xiang
Background: Handelin is a bioactive compound from Chrysanthemum indicum L. that improves motor function and muscle integrity during aging in Caenorhabditis elegans. This study aimed to further evaluate the protective effects and molecular mechanisms of handelin in a mouse muscle atrophy model induced by cachexia and aging.Methods: A tumour necrosis factor (TNF)‐α‐induced atrophy model was used to examine handelin activity in cultured C2C12 myotubes in vitro. Lipopolysaccharide (LPS)‐treated 8‐week‐old model mice and 23‐month‐old (aged) mice were used to examine the therapeutic effects of handelin on cachexia‐ and aging‐induced muscle atrophy, respectively, in vivo. Protein and mRNA expressions were analysed by Western blotting, ELISA and quantitative PCR, respectively. Skeletal muscle mass was measured by histological analysis.Results: Handelin treatment resulted in an upregulation of protein levels of early (MyoD and myogenin) and late (myosin heavy chain, MyHC) differentiation markers in C2C12 myotubes (P < 0.05), and enhanced mitochondrial respiratory (P < 0.05). In TNF‐α‐induced myotube atrophy model, handelin maintained MyHC protein levels, increased insulin‐like growth factor (Igf1) mRNA expression and phosphorylated protein kinase B protein levels (P < 0.05). Handelin also reduced atrogin‐1 expression, inhibited nuclear factor‐κB activation and reduced mRNA levels of interleukin (Il)6, Il1b and chemokine ligand 1 (Cxcl1) (P < 0.05). In LPS‐treated mice, handelin increased body weight (P < 0.05), the weight (P < 0.01) and cross‐sectional area (CSA) of the soleus muscle (P < 0.0001) and improved motor function (P < 0.05). In aged mice, handelin slightly increased the weight of the tibialis anterior muscle (P = 0.06) and CSA of the tibialis anterior and gastrocnemius muscles (P < 0.0001). In the tibialis anterior muscle of aged mice, handelin upregulated mRNA levels of Igf1 (P < 0.01), anti‐inflammatory cytokine Il10 (P < 0.01), mitochondrial biogenesis genes (P < 0.05) and antioxidant‐related enzymes (P < 0.05) and strengthened Sod and Cat enzyme activity (P < 0.05). Handelin also reduced lipid peroxidation and protein carbonylation, downregulated mRNA levels of Fbxo32, Mstn, Cxcl1, Il1b and Tnf (P < 0.05), and decreased IL‐1β levels in serum (P < 0.05). Knockdown of Hsp70 or using an Hsp70 inhibitor abolished the ameliorating effects of handelin on myotube atrophy.Conclusions: Handelin ameliorated cachexia‐ and aging‐induced skeletal muscle atrophy in vitro and in vivo, by maintaining homeostasis of protein synthesis and degradation, possibly by inhibiting inflammation. Handelin is a potentially promising drug candidate for the treatment of muscle wasting.

Verified
Journal Article
Open access
PDF file
THTiane Huang
Tiane Huang
JZJing Zhou
Jing Zhou
BWBenhui Wang
Benhui Wang
XWXiang Wang
Xiang Wang
WXWanli Xiao
Wanli Xiao
XLXin-Qiang Lan
Xin-Qiang Lan
Skeletal muscle differentiation is a precisely coordinated process. While many of the molecular details of myogenesis have been investigated extensively, the dynamic changes and functions of amino acids and related transporters remain unknown. In this study, we conducted a comprehensive analysis of amino acid levels during different time points of C2C12 myoblast differentiation using high-performance liquid chromatography (HPLC). Our findings revealed that the levels of most amino acids exhibited an initial increase at the onset of differentiation, reaching their peak typically on the fourth or sixth day, followed by a decline on the eighth day. Particularly, arginine and branched-chain amino acids showed a prominent increase during this period. Furthermore, we used RNA-seq analysis to show that the gene encoding the arginine transporter, Slc7a2, is significantly upregulated during differentiation. Knockdown of Slc7a2 gene expression resulted in a significant decrease in myoblast proliferation and led to a reduction in the expression levels of crucial myogenic regulatory factors, hindering the process of myoblast differentiation, fusion, and subsequent myotube formation. Lastly, we assessed the expression level of Slc7a2 during aging in humans and mice and found an upregulation of Slc7a2 expression during the aging process. These findings collectively suggest that the arginine transporter SLC7A2 plays a critical role in facilitating skeletal muscle differentiation and may hold potential as a therapeutic target for sarcopenia.

2 September 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
WXWanli Xiao
Wanli Xiao
THTian-E Huang
Tian-E Huang
JZJing Zhou
Jing Zhou
BWBenhui Wang
Benhui Wang
XWXiang Wang
Xiang Wang
YXYang Xiang
Yang Xiang
The regenerative capacity of muscle, which primarily relies on anabolic processes, diminishes with age, thereby reducing the effectiveness of therapeutic interventions aimed at treating age-related muscle atrophy. In this study, we observed a decline in the expression of methionine adenosine transferase 2A (MAT2A), which synthesizes S-adenosylmethionine (SAM), in the muscle tissues of both aged humans and mice. Considering MAT2A’s critical role in anabolism, we hypothesized that its reduced expression contributes to the impaired regenerative capacity of aging skeletal muscle. Mimicking this age-related reduction in the MAT2A level, either by reducing gene expression or inhibiting enzymatic activity, led to inhibiting their differentiation into myotubes. In vivo, inhibiting MAT2A activity aggravated BaCl2-induced skeletal muscle damage and decreased the number of satellite cells, whereas supplementation with SAM improved these effects. RNA-sequencing analysis further revealed that the Fas cell surface death receptor (Fas) gene was upregulated in Mat2a-knockdown C2C12 cells. Suppressing MAT2A expression or activity elevated Fas protein levels and increased the proportion of apoptotic cells. Additionally, inhibition of MAT2A expression or activity increased p53 expression. In conclusion, our findings demonstrated that impaired MAT2A expression or activity compromised the regeneration and repair capabilities of skeletal muscle, partially through p53–Fas-mediated apoptosis.

8 September 2023 in The FASEB Journal
Verified
Journal Article
Open access
HZHuijie Zhang
Huijie Zhang
WZWeirong Zeng
Weirong Zeng
MZMing‐Ming Zhao
Ming‐Ming Zhao
JWJiali Wang
Jiali Wang
QWQiquan Wang
Qiquan Wang
YXYang Xiang
Yang Xiang
Aerolysin‐like pore‐forming protein (af‐PFP) superfamily members are double‐edge swords that assist the bacterial infection but shied bacteria from the host by various mechanisms in some species including the toad Bombina maxima and zebrafish. While members of this family are widely expressed in all kingdoms, especially non‐bacteria species, it remains unclear whether their anti‐bacterial function is conserved. LIN‐24 is an af‐PFP that is constitutively expressed throughout the Caenorhabditis elegans lifespan. Here, we observed that LIN‐24 knockdown reduced the maximum lifespan of worms. RNA‐seq analysis identified 323 differentially expressed genes (DEGs) post‐LIN‐24 knockdown that were enriched in “immune response” and “lysosome pathway,” suggesting a possible role for LIN‐24 in resisting microbial infection. In line with this, we found that Pseudomonas aeruginosa 14 (PA14) infection induced LIN‐24 expression, and that survival after PA14 infection was significantly reduced by LIN‐24 knockdown. In contrast, LIN‐24 overexpression (LIN‐24‐OE) conferred protection against PA14 infection, with worms showing longer survival time and reduced bacterial load. Weighted gene co‐expression network analysis of LIN‐24‐OE worms showed that the highest correlation module was enriched in factors related to immunity and the defense response. Finally, by predicting transcription factors from RNA‐seq data and knocking down candidate transcription factors in LIN‐24‐OE worms, we revealed that LIN‐24 may protect worms against bacterial infection by stimulating DAF‐16‐mediated immune responses. These findings agree with our previous studies showing an anti‐microbial role for the amphibian‐derived af‐PFP complex βγ‐CAT, suggesting that af‐PFPs may play a conserved role in combatting microbial infections. Further research is needed to determine the roles this protein family plays in other physio‐pathological processes, such as metabolism, longevity, and aging.

29 January 2026 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
QWQiquan Wang
Qiquan Wang
JLJian Li
Jian Li
MYMengqi Yang
Mengqi Yang
CGCaifen Guo
Caifen Guo
MZMing Zhang
Ming Zhang
YXYang Xiang
Yang Xiang
Background: Cachexia, characterized by severe weight loss and muscle atrophy, frequently occurs in chronic conditions such as sepsis, cancer and chemotherapy, with limited effective treatments. Despite similar clinical manifestations, the underlying mechanisms across different disease contexts remain unclear. Identifying common pathways could lead to novel therapies. This study examines the role of Toll‐like receptor 4 (TLR4), which is upregulated in various cachexia models, and assesses the therapeutic potential of the TLR4‐inhibiting peptide OH‐CATH30 in mitigating muscle atrophy. Methods: In vivo models using 8‐week‐old mice treated with lipopolysaccharide (LPS), 4T1 tumour cells and cisplatin were used to investigate common pathways in cachexia. In vitro models were established by treating C2C12 myotubes with TNF‐α, 4T1 culture supernatants and cisplatin. OH‐CATH30's effects on muscle atrophy were assessed by measuring myotube diameter, grip strength, muscle weight and muscle fibre cross‐sectional area (CSA) via H&E staining. RNA‐seq, qPCR, ELISA and Western blotting were performed to explore pathways in cachexia‐induced muscle atrophy and OH‐CATH30's action mechanism. Results: Transcriptomic analysis showed significant enrichment of inflammation and protein degradation pathways in skeletal muscle in LPS‐induced sepsis, 4T1 tumour‐induced cancer cachexia and cisplatin‐induced cachexia models, with upregulated expression of TLR4 pathway genes such as Cd14 , Tlr4 and Irak4 ( p < 0.05). In myotube atrophy models induced by TNF‐α, 4T1 and cisplatin, OH‐CATH30 significantly increased MyHC protein levels ( p < 0.05) and myotube diameter ( p < 0.05). In mouse cachexia models induced by LPS, 4T1 and cisplatin, OH‐CATH30 treatment significantly increased body weight ( p < 0.05), muscle weight ( p < 0.001), CSA ( p < 0.05) and improved grip strength ( p < 0.05). Transcriptomic analysis further revealed that OH‐CATH30 treatment downregulated expression of inflammation and protein degradation‐related genes across all cachexia models. In 4T1‐treated mice, qPCR confirmed OH‐CATH30 reduced mRNA levels of Il6 ( p = 0.05), Mstn ( p < 0.0001) and protein degradation genes such as Trim63 , Fbxo32 , Bnip3 , Gabarapl1 and Ulk1 ( p < 0.05). ELISA showed reduced serum IL‐6 levels, and Western blot confirmed downregulation of atrogin1 ( p < 0.05) and autophagy marker LC3II ( p < 0.05) with OH‐CATH30 treatment. Pharmacological inhibition of TLR4 using TAK‐242 recapitulated the protective effects of OH‐CATH30, with no additive benefit observed ( p > 0.05). Conclusions: Our findings underscore the critical role of TLR4 signalling in cachexia‐associated muscle wasting across different disease contexts and demonstrate the efficacy of OH‐CATH30, a TLR4 inhibitor, in alleviating muscle atrophy in various cachexia models.

6 February 2025 in Toxins
Verified
Journal Article
Open access
PDF file
XLXin-Qiang Lan
Xin-Qiang Lan
MYMengqi Yang
Mengqi Yang
JWJiali Wang
Jiali Wang
CHChunping Huang
Chunping Huang
AWAndong Wu
Andong Wu
QWqiquan wang
qiquan wang
The ability to survive starvation is a critical evolutionary adaptation, yet the molecular mechanisms underlying this capability remain incompletely understood. Pore-forming proteins (PFPs) are typically associated with immune defense, where they disturb the membranes of target cells. However, the role of PFPs in non-immune functions, particularly in metabolic and structural adaptations to starvation, is less explored. Here, we investigate the aerolysin-like PFP LIN-24 in Caenorhabditis elegans and uncover its novel function in enhancing starvation resistance. We found that LIN-24 expression is upregulated during starvation, leading to increased expression of the lipase-encoding gene lipl-3. This upregulation accelerates the mobilization and degradation of lipid stores, thereby sustaining energy levels. Additionally, LIN-24 overexpression significantly preserves muscle integrity, as evidenced by the maintenance of muscle structure compared to wild-type worms. Furthermore, we demonstrate that LIN-24 induces the formation of donut-shaped mitochondria, a structural change likely aimed at reducing ATP production to conserve energy during prolonged nutrient deprivation. This mitochondrial remodeling depends on genes involved in mitochondrial dynamics, including mff-1, mff-2, drp-1, and clk-1. Collectively, these findings expand our understanding of PFPs, demonstrating their multifaceted role in stress resistance beyond immune defense. LIN-24’s involvement in regulating metabolism, preserving muscle structure, and remodeling mitochondria highlights its crucial role in the adaptive response to starvation, offering novel insights into the evolution of stress resistance mechanisms and potential therapeutic targets for conditions related to muscle preservation and metabolic regulation.